Skip to content

Rasayana effect of Bharangi Guda in patients who were affected and recovered by COVID19

The Clinical study to evaluate the Rasayana effect of Bharangi Guda IN Post COVID subjects

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039728
Enrollment
30
Registered
2022-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B342- Coronavirus infection, unspecified Health Condition 3: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

None listed

Sponsors

DR ROOPA N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: postcovid subject with signs and symptoms of fatigue dyspnoea disturbed sleep cough anorexia and weight loss haemoglobin greater than 8gm/dl upto 1year subjects will be considered for study once he diagnosed as covid19 positive during trial sobjects PTPCR report must be negative subjects who are vaccinated eith 1stdose or both the doses subjects must have either RT[CR or RAT reports positve to claim that they have exposed to SARS CoV 2 virus

Exclusion criteria

Exclusion criteria: Patient having history of Diabetes mellitus Other Systemic diseases like Sexual transmitted diseases Acquired immuno deficiency virus etc Other postcovid complications like Mucormycosis Pregnant and lactating mothers are excluded from the study

Design outcomes

Primary

MeasureTime frame
Assessment of fatigue by Chalder fatigue scale from grade3 to grade0 Anorexia assessment from Grade3 to grade0 Disturbed sleep by Sleep quality scale from Grade3 to Grade0 Cough by MEG Cough severity index scale from grade4 to grade0 Dyspnoea by medical research council dyspnoea scale from grade5 to grade0 Weight by manual check increase at final assessmentTimepoint: Assessment will be done at baseline, 15th day, 30th day and 50th day

Secondary

MeasureTime frame
Increase in values of CBC values Changes in IgG and IgM Decrease in CRP values Timepoint: 45days

Countries

India

Contacts

Public ContactDR SANTOSH N BELAVADI

SHRI D G M AYURVEDIC MEDICAL COLLEGE AND HOSPITAL POST GRADUATE STUDIES AND RESEARCH CENTRE GADAG

hardikasnb@gmail.com9886916367

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026